Process/Project Engineering Co-op
About the job
- Candidates must be legally authorized to work in the United States and must not require employment visa sponsorship now or in the future.
- Candidates must be actively enrolled in an accredited university through the duration of the co-op assignment and pursuing a Bachelor's or Master's degree focused in Chemical, Mechanical, Industrial, Packaging, Systems, Computer, Biomedical, or Electrical Engineering.
- Candidates must be able to commit to at least four months, working a minimum of 40 hours per week Monday through Friday, for the length of the assignment.
- Candidates must be able to work fully onsite in Fort Washington, Pennsylvania.
- Candidates must have a minimum cumulative GPA of 3.0; this qualification is highly preferred.
- Candidates must be proficient in Windows software applications, including Excel, PowerPoint, Word, and Outlook.
- Candidates must be able to provide their own daily transportation between home and the work location.
- Support daily onsite activities within the facility, including project management support.
- Perform data analysis and root cause problem solving.
- Support the development and implementation of innovative methods to improve site processes and performance metrics.
- Support validation activities.
- Demonstrate strong analytical and organizational skills.
- Demonstrate willingness to learn and strong problem-solving skills, and be capable of working in a fast-paced environment.
- Demonstrate the ability to manage multiple projects and initiatives while maintaining a strong sense of urgency.
- Have experience with Minitab or other statistical tools, Tableau, Power BI, or similar dashboard and reporting tools.
- Have a passion for the consumer health industry.
Kenvue is currently recruiting for a:
What we do
At Kenvue, we realize the extraordinary power of everyday care. Built on over a century of heritage and rooted in science, we’re the house of iconic brands - including NEUTROGENA®, AVEENO®, TYLENOL®, LISTERINE®, JOHNSON’S® and BAND-AID® that you already know and love. Science is our passion; care is our talent.
Who We Are
Our global team is ~ 22,000 brilliant people with a workplace culture where every voice matters, and every contribution is appreciated.We are passionate about insights, innovation and committed to delivering the best products to our customers. With expertise and empathy, being a Kenvuer means having the power to impact millions of people every day. We put people first, care fiercely, earn trust with science and solve with courage – and have brilliant opportunities waiting for you! Join us in shaping our future–and yours. For more information, click here.
Role reports to:
Sr. Manager, Manufacturing ExcellenceLocation:
North America, United States, Pennsylvania, Fort WashingtonWork Location:
Fully OnsiteWhat you will do
The Process/Project Engineering Co-Op is a 4 to 9 month experience designed to help college students develop leadership, technical, and communication skills through practical business experience and ongoing training, development, coaching and mentorship. This role will enable the student to have real-life work application of concepts and theories learned in the classroom in a consumer products manufacturing facility. This is an full-time (minimum 40 hours per week) on-site assignment.
Key Responsibilities
Support of daily activities on-site within the facility, including but not limited to:
- Project Management Support.
- Data Analysis and Root Cause Problem Solving.
- Supporting the development and implementation of innovative methods to improve site processes and performance metrics.
- Validation Activity Support.
What we are looking for
Required Qualifications
- Candidates must be legally authorized to work in the United States and must not require sponsorship for employment visa status now or in the future (e.g. H1-B status)
- Actively enrolled in an accredited university through the duration of co-op assignment pursuing a Bachelor’s or Master’s degree focused in: Engineering (Chemical, Mechanical, Industrial, Packaging, Systems, Computer, Bio-Medical, Electrical)
- Ability to commit to at least a 4 month duration, minimum 40 hours per week (Monday – Friday) for the length of the assignment, starting in January 2027 and continuing through April 2027 with an opportunity to extend through September 2027
- Ability to work fully on-site in Fort Washington, PA
- Minimum cumulative 3.0 GPA is highly preferred
- Proficient in Windows software applications (Excel, PowerPoint, Word, Outlook)
- Ability to provide their own transportation between home and work location on a daily basis
Desired Qualifications
- Exhibits strong analytical, organizational and communication skills
- Displays willingness to learn, strong problem-solving skills and capable of working in a fast-paced environment
- Demonstrates ability to manage multiple projects and initiatives while maintaining a strong sense of urgency
- Demonstrated experience with Minitab or other statistical tools, Tableau, PowerBI or similar dashboard / reporting tools
- Passionate about the consumer health industry
What’s in it for you
Hourly pay rate for new hires in this position ranges:
$20.00 - $45.00
This takes into account a number of factors including work location, the candidate’s skills, experience, education level & other job-related factors.
Competitive Benefit Package*
Paid Company Holidays, Paid Vacation, Volunteer Time & More!
Learning & Development Opportunities
Kenvuer Impact Networks
This list could vary based on location/region
*Note: Total Rewards at Kenvue include salary, bonus (if applicable) and benefits. Your Talent Access Partner will be able to share more about our total rewards offerings and the specific salary range for the relevant location(s) during the recruitment & hiring process.
Kenvue is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment based on merit without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
If you are an individual with a disability, please check our Disability Assistance page for information on how to request an accommodation.
About the company
Kenvue is the world’s largest pure-play consumer health company by revenue, developing, manufacturing, and selling a broad portfolio of over-the-counter medicines, personal care, skincare, and wound care products. Its brands, including Tylenol, Motrin, Zyrtec, Benadryl, Nicorette, Neutrogena, Aveeno, Band-Aid, Listerine, and Johnson’s, address everyday health needs through an omnichannel model that reaches consumers in 165+ countries via retailers and direct-to-consumer e-commerce. The company differentiates itself with a long history of science-backed brands and a global distribution network, grown from the Johnson & Johnson spin-off, and it emphasizes brand-building and data-driven marketing. Its goal is to maintain market leadership in consumer health, grow its brands and channels (including direct-to-consumer), and pursue strategic options while expanding globally.
Company Size
10,001+
Company Stage
IPO
Headquarters
Montgomery Township, New Jersey
Founded
2023
Get referred to Kenvue
See people who can refer or advise you
Simplify's Take
What believers are saying
- Kenvue reported Q2 2026 net sales up 3.0% and organic sales up 1.6%.
- Kenvue’s 2026 restructuring should cut 3.5% of jobs and remove $250 million costs.
- Kirk Perry said on August 6, 2026 the Kimberly-Clark combination remains on track.
What critics are saying
- The Second Circuit revived 500-plus Tylenol lawsuits on July 13, 2026.
- Texas Attorney General Ken Paxton’s Tylenol case survived dismissal on February 26, 2026.
- Kimberly-Clark’s $48.7 billion acquisition depends on foreign approvals and antitrust remedies through Q4 2026.
What makes Kenvue unique
- Kenvue owns Tylenol, Neutrogena, Listerine, and Band-Aid, each billion-dollar brand.
- Kirk Perry pushed science-led Neutrogena and Aveeno launches at AAD 2026.
- Kenvue’s 2026 restructuring targets supply-chain simplification and consumer-health specialization before the Kimberly-Clark deal.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Paid Vacation
- Paid Company Holidays
- Learning & Development Opportunities
- Competitive Benefit Package
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
0%Kenvue will leave the S&P 500 before the open on November 4, 2026, replaced by Okta, S&P Dow Jones Indices announced on October 30. Kimberly-Clark is acquiring the maker of Tylenol, Neutrogena, Listerine, and BAND-AID products. Kenvue holders will receive $3.50 in cash plus 0.14625 Kimberly-Clark shares per share, valued at $21.01 per share when announced on November 3, 2025. Kimberly-Clark holders will own about 54% of the combined company, and Kenvue holders about 46%. Okta, up 136% this year, moves up from the S&P MidCap 400, so funds tracking the S&P 500 must buy it. No closing date for the deal has been announced. Kenvue holders should watch Kimberly-Clark's first dividend after closing. A cut to its $1.28 quarterly payout would weaken the income case for staying on.
SKMG brings in new hire to launch deep tech division. 2 November 2026 12:33 AM 2 mins read Executive advisory and communications consultancy, SKMG, has appointed Gabrielle Dunbar as Associate Director, Deep Technology. She will lead the new division, helping founders communicate complex technologies to investors, prospective employees, and policymakers. Gabrielle joins SKMG from London, where she was a Director at deep tech communications firm, Commplicated. There, she worked with university spinouts and early stage startups, across quantum technology, AI, advanced materials, defence, and biotech. Her work included announcements for funding rounds, VC fund launches, partnerships, technical milestones, and scientific publications. Prior to that, Gabrielle spent eight years at Champion Communications, running campaigns for global cloud, data centre, and SaaS companies across EMEA, North America, and APAC. She also helped launch several businesses into new markets, including a hospitality tech company into Australia and New Zealand. SKMG Co-founder, Neil Shoebridge, said: "The deep tech sector is growing rapidly in Australia and already has the highest rate of turning out unicorns for comparatively low capital investment in the world. Deep tech founders require specialised expertise to tell their story and fund expansion. "With her extensive experience and great track record in the UK, plus an impressive understanding of the Australian market, Gabrielle is the perfect person to do that. We are delighted that she agreed to join the SKMG team." SKMG Co-founder, Andrew Knowles, said: "The founders and changemakers we work with have already done the hard part: creating something that works. We're proud to be growing the business they trust to ensure investors, hires, and policymakers understand the value in what they are building. "We're currently working with clients tackling the Australian housing crisis, delivering renewable solutions to energy security in Africa, protecting Australian copyright against AI and leading the science of word of mouth. Gabrielle is a remarkably adept operator who understands how founders think, what they need, and how to maximise value. We're so excited to have her on board." Telum media creating connections. Book a demo You might also enjoy. Chris Lee has joined Ennismore as Brand & PR Director APAC. She has wrapped up two and a half years at EVT's Luxury portfolio, leading QT Hotels & Resorts as Brand Manager. Prior to this, Chris held comms and partnership roles at QT Hotels & Resorts, and Ovolo Hotels. 1 November 2026 11:24 PM Natalie Turner has joined Kenvue as Corporate Affairs Manager. She was at IKEA for nearly seven years, most recently as Communications Operations Manager. Prior to this, Natalie was at Kimberly-Clark for nearly nine years, where she held multiple comms roles. 1 November 2026 11:17 PM The Earned View Are communicators confusing the durability of a message with the durability of its emotional effect? Reassurance can have a remarkably short half-life. A confident statement from a chief executive can restore optimism. A compelling vision can make an uncertain future feel manageable. A clear explanation of a difficult decision can temporarily settle an anxious workforce. But the relief doesn't necessarily last. Sometimes it survives for weeks. Sometimes only days. Occasionally, another question emerges before the leadership briefing has even finished. Nothing material has changed. The information remains valid. The leader is no less credible. Yet the anxiety returns, demanding another explanation, another demonstration of confidence, another reason to believe things might turn out well. When the message isn't the problem. Much of strategic communication is concerned with ensuring that messages are understood, believed and remembered. We develop narratives, establish credible spokespeople, build communication programs, and measure whether audiences are receiving and accepting what we tell them. When anxiety persists, our instinct is often to communicate again. Refine the narrative. Increase leadership visibility. Find another way to demonstrate confidence. Sometimes that's precisely what's required. But consider an organisation undergoing a significant restructure. An employee attends a leadership briefing and receives a clear explanation of the organisation's direction. They understand the rationale for change, believe the chief executive is acting in good faith, and accept that difficult decisions are necessary. They may even leave feeling reassured. The following morning, however, they wake up worried about whether they'll still have a job in six months. The message hasn't been forgotten. Their confidence in the chief executive hasn't necessarily diminished. The uncertainty has simply become frightening again. What, exactly, has the communication failed to achieve? Perhaps nothing. Perhaps we've been treating the persistence of anxiety as evidence that a message hasn't landed, when the real problem is that the uncertainty itself remains unresolved. Psychological research into reassurance-seeking suggests that repeated reassurance can temporarily reduce distress without necessarily addressing the underlying anxiety. In some circumstances, the relief can reinforce the impulse to seek reassurance again. I wonder whether something similar happens in organisational communication. When people return repeatedly for information, are they always seeking answers to new questions? Or are they sometimes looking for renewed confirmation of something they already understand? The distinction matters because one is an information problem. The other may not be. The reassurance of leadership. This becomes more complicated when we consider what people expect from leaders. Part of leadership is making an uncertain future feel real. Giving people a credible sense of where they're going, why it matters and why they should believe the journey is possible. Strategic communication plays a central role in making that future comprehensible and believable. But how often does that sense of confidence need to be renewed? An organisation navigating prolonged change may communicate frequently and effectively while its employees remain deeply anxious. Another town hall is scheduled. Another leadership update is circulated. Another opportunity is created to demonstrate confidence. Is that evidence that the previous communication was insufficient? Or is it simply what people need when uncertainty continues? Perhaps repeated reassurance isn't necessarily a failure of leadership. Perhaps it's part of what leadership requires. But there is another possibility worth considering. A leader who repeatedly provides reassurance may become increasingly important to an anxious audience, even when the underlying uncertainty remains unresolved. People attend briefings, seek guidance, and return to official channels. We might reasonably interpret that engagement as evidence of trust. But could it also reflect an ongoing need for reassurance? And might the two sometimes be difficult to distinguish? Get weekly access to insights from the regions that matter to you. 1 November 2026 11:00 PM 7 mins read
Kenvue reports 3.2% Q3 sales growth, EPS up 5%
224,557 Kenvue Inc. $KVUE shares sold by Vest Financial LLC. October 22, 2026 Key points. * Vest Financial reduced its Kenvue stake by 8.0% in the third quarter, selling 224,557 shares and retaining 2.58 million shares valued at approximately $45.6 million. Institutional investors and hedge funds collectively own 97.64% of the company. * Kenvue reported quarterly revenue of $3.96 billion, up 3.0% year over year, but earnings of $0.31 per share fell short of analysts' $0.32 estimate. The company maintains a quarterly dividend of $0.21, equivalent to a 4.4% annualized yield. * Analysts largely remain cautious, with a consensus "Hold" rating and an average price target of $18.43, below the reported share price of $19.05. * Tracking Kenvue through earnings season? MarketBeat All Access sends real-time alerts on ratings, earnings, and news - $149 a year, locked in for as long as you stay. Vest Financial LLC cut its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 8.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,582,290 shares of the company's stock after selling 224,557 shares during the period. Vest Financial LLC owned 0.13% of Kenvue worth $45,603,000 as of its most recent filing with the Securities and Exchange Commission. Other large investors also recently modified their holdings of the company. Johnson Financial Group Inc. bought a new position in Kenvue in the 2nd quarter worth approximately $26,000. GK Wealth Management LLC acquired a new position in Kenvue during the 3rd quarter worth $27,000. CoreCap Advisors LLC lifted its holdings in Kenvue by 64.9% during the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after buying an additional 591 shares in the last quarter. Bell Investment Advisors Inc bought a new position in Kenvue in the 2nd quarter valued at $35,000. Finally, Keating Financial Advisory Services Inc. bought a new position in Kenvue in the 2nd quarter valued at $38,000. 97.64% of the stock is currently owned by institutional investors and hedge funds. Kenvue trading down 1.2%. Shares of NYSE KVUE opened at $19.05 on Thursday. The company's 50 day simple moving average is $18.33 and its 200 day simple moving average is $18.24. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.13. The firm has a market capitalization of $36.58 billion, a P/E ratio of 16.34, a P/E/G ratio of 1.77 and a beta of 0.48. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same period in the previous year, the business posted $0.29 earnings per share. Kenvue's revenue was up 3.0% compared to the same quarter last year. On average, analysts predict that Kenvue Inc. will post 1.14 EPS for the current year. Kenvue dividend announcement. The business also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Stockholders of record on Monday, September 21st were paid a $0.21 dividend. The ex-dividend date of this dividend was Monday, September 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue's dividend payout ratio is 96.55%. Analyst upgrades and downgrades. Several research firms have recently commented on KVUE. Weiss Ratings reissued a "hold (c)" rating on shares of Kenvue in a research note on Friday, September 11th. UBS Group dropped their target price on Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, August 11th. Barclays upped their price target on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. Wall Street Zen cut Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Finally, Zacks Research cut Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Ten analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Kenvue has a consensus rating of "Hold" and an average target price of $18.43. Discover more Read Company News Track Biotech Refill Meds Kenvue profile. Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels. The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson's and OGX in oral care, baby care and hair care. Further reading. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Kenvue, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list. While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall. Continue following MarketBeat
NIQ Global Intelligence: NielsenIQ Appoints Puneet Sharma as Managing Director, India. Published on 10/07/2026 at 09:22 am EDT Mumbai, India - September XX, 2026 - NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the appointment of Puneet Sharma as Managing Director, India, effective September 30, 2026. Based in Mumbai, Puneet will lead NIQ India's commercial strategy and business operations, with focus on accelerating growth, strengthening client partnerships, expanding market presence, and advancing NIQ's consumer, retail, digital, and e-commerce intelligence capabilities across one of the world's most dynamic consumer markets. "Puneet joins NIQ at a pivotal moment for both our business and the Indian market," said Daniel Chorbadjian, Regional President, EEMEA and India, NIQ. "As consumer behavior continues to evolve and clients increasingly seek integrated intelligence across retail, e-commerce, digital, and consumer insights, India represents a significant opportunity for growth and innovation. Puneet's brings deep market knowledge, commercial expertise, and extensive experience building customer relationships. His leadership will be instrumental strengthen our position in India and create even greater value for our clients." India remains one of NIQ's most important strategic growth markets globally, driven by rising consumer spending, rapid digitalization, the expansion of modern trade, and the increasing convergence of online and offline commerce. NIQ continues to invest in advanced measurement capabilities, technology, talent, and innovation to help clients better understand changing consumer behavior and make more confident business decisions. Puneet's appointment reflects the company's long-term commitment to the market. Puneet brings more than two decades of leadership experience across leading consumer and service businesses, with a career spanning J&J / Kenvue, The Coca-Cola Company, Bacardi, BCCL (Times Group), Aircel, and Carrier. Across these roles, he has built extensive experience in commercial strategy, sales leadership, customer engagement, go-to-market transformation and developing high-performing teams. Most recently, Puneet served as Sales Director at Kenvue, where he played a key role in shaping commercial strategy, strengthening customer and channel partnerships, and driving transformation across a rapidly evolving consumer landscape. Prior to Kenvue, Puneet held leadership roles across a diverse set of businesses and categories, building a career defined by navigating complex markets, developing strong customer relationships and translating strategy into sustainable business growth. "I am excited to join NIQ at a time of tremendous opportunity for both the company and the Indian market," said Puneet Sharma. "India's consumer ecosystem is transforming quickly, creating new possibilities for businesses to innovate, compete, and grow. NIQ is uniquely positioned to help clients navigate that change by connecting comprehensive consumer and retail inrelligence, technology, and measurement capabilities. I look forward to working with our teams and clients to build on NIQ's strong foundation in India, accelerate growth and identify new opportunities in this dynamic market." NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action. With operations in more than 90 countries, NIQ covers approximately 82% of the world's population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View(TM)-helping brands and retailers understand what consumers buy, why they buy it, and what to do next. Forward-Looking Statement This press release about the appointment of NIQ's new Managing Director contains forward-looking statements regarding NIQ's strategy, commercial execution, and strategic initiatives. These statements reflect current expectations and projections based on available data, historical patterns, and various assumptions. Words such as 'will,' 'accelerate,' 'expanding,' 'positions,' 'designed to,' 'evolve,' 'expects,' 'anticipates,' and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future outcomes and are subject to inherent uncertainties, including changes in consumer preferences, economic conditions, technological advancements, competitive dynamics, and the ability to retain key talent and successfully transition leadership responsibilities. Actual results may differ materially from those expressed or implied in these statements. Additional information on these and other risks is contained in the "Risk Factors" section of NIQ's most recent Annual Report on Form 10-K and its subsequent filings with the U.S. Securities and Exchange Commission, available at www.sec.gov. While we strive to base our insights on reliable data and sound methodologies, we undertake no obligation to update any forward-looking statements to reflect future events or circumstances, except to the extent required by applicable law. NielsenIQ Appoints Puneet Sharma as Managing Director, India Attachments * Original document * Permalink Disclaimer NIQ Global Intelligence plc published this content on October 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 07, 2026 at 13:21 UTC. (C) Publicnow - 2026